Göran Forsberg

Göran Forsberg is the founder of Trainparts Sweden AB, founded in 2014.
Current jobs include Director at Mesenkia Therapeutics AB starting in 2025 and Independent Non-Executive Director at Disruptive Pharma AB starting in 2026.
Former jobs include Chief Executive Officer at Cantargia AB from 2014 to 2025, Non-Executive Director at Isogenica Ltd., Director at Active Security Trading AB, Director at Active Biotech Research AB, Director at Actinova AB, Independent Director at Guard Therapeutics International AB, Head-Business Development & Investor Relation at the University of Adelaide, Head-Business Development & Investor Relation at Kabigen AB, and Chief Business Officer & VP-Investor Relations at Active Biotech AB from 2011 to 2014.